Coronary Artery Bypass Clinical Trial
— SCCABOfficial title:
An Observational Cohort Study of Associations Between Early Neurological Complications(Including Stroke)and Carotid-Cerebral Vascular Disease Among Patients After Coronary Artery Bypass Grafting
NCT number | NCT05036044 |
Other study ID # | KY-2021127 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | September 4, 2021 |
Est. completion date | May 31, 2023 |
Verified date | July 2023 |
Source | Ruijin Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Review the data of patients who underwent coronary artery bypass grafting (CABG) at the Department of Cardiovascular Surgery in Ruijin hospital from March 2020 to May 2022, including medical history, head and neck CTA, head CT scan, and early postoperative (within 7 days after surgery) neurological complications (defined as a composite of stroke, delayed awakening and severe delirium) . Case-control and retrospective cohorts were built to explore risk factors of early postoperative neurological complications, And its association with baseline carotid-cerebral vascular disease. Describe the epidemiological data of early postoperative neurological complications (stroke, delayed awakening, and severe delirium) after CABG surgery (within 7 days after surgery); explore independent risk factors of compound neurological complications, build predictive models; compare the effects of carotid-cerebral artery disease on early postoperative compound neurological complications.
Status | Completed |
Enrollment | 1002 |
Est. completion date | May 31, 2023 |
Est. primary completion date | January 21, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: 1. Patients who received CABG at the department of cardiac surgery in our hospital. 2. Surgery that patients received includes both isolated and combined CABG surgery. 3. Includes both cardiopulmonary and non-cardiopulmonary bypass. Exclusion Criteria: 1. Without complete preoperative examination data, such as carotid-cerebral artery CTA, head CT imaging results and so on. 2. Without complete baseline medical history and 7 day post-surgery record. |
Country | Name | City | State |
---|---|---|---|
China | Ruijin Hospital Shanghai Jiao Tong University School of Medicine | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Ruijin Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the incidence of 7-day neurological complications | a composite of stroke, delayed awakening, severe delirium | within 7 days post-CABG | |
Primary | the incidence of 7-day stroke | including cerebral infarction, cerebral hemorrhage, and hypoxic-ischemic encephalopathy | within 7 days post-CABG | |
Primary | the incidence of delayed awakening | post-surgery patient does not wake up at 48 hours after withdrawing sedative | within 48 hours post-CABG | |
Primary | the incidence of severe delirium | ICU CAM-II score=2 points | within 7 days post-CABG | |
Secondary | the incidence of All-cause death | Death from any cause | 7 days, 30 days and 1 year post-CABG | |
Secondary | the incidence of CV-death | Including death resulting from an acute myocardial infarction , sudden cardiac death, death due to heart failure, death due to stroke, death due to cardiovascular procedures, death due to cardiovascular hemorrhage, and death due to other cardiovascular causes | 7 days, 30 days and 1 year post-CABG | |
Secondary | the incidence of myocardial infraction | According to the 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials, including CABG-related MI, non CABG-related MI, silent MI and unknown type. | 7 days, 30 days and 1 year post-CABG | |
Secondary | the incidence of repeat revascularization | any PCI and CABG. | 7 days, 30 days and 1 year post-CABG |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03235323 -
Efficacy of External CounterPulsation for Postoperative Coronary Artery Bypass Grafting Patients
|
N/A | |
Recruiting |
NCT05010460 -
Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting
|
Phase 2 | |
Completed |
NCT03622671 -
Fibrin Clot Properties and Blood Loss Following Coronary Artery By-pass Grafting
|
N/A | |
Completed |
NCT00400790 -
Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane
|
N/A | |
Not yet recruiting |
NCT03275220 -
Assessment Of Right Ventricular Function In Patients Undergoing Coronary Artery Bypass Graft In Assiut University
|
N/A | |
Completed |
NCT01256372 -
An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery
|
Phase 2 | |
Completed |
NCT00489827 -
Glutamate for Metabolic Intervention in Coronary Surgery
|
Phase 3 | |
Completed |
NCT04591119 -
Transversus Thoracis Muscle Plane Block for Postoperative Pain in Adult Cardiac Surgery
|
N/A | |
Active, not recruiting |
NCT03908593 -
Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG
|
Phase 4 | |
Recruiting |
NCT03774342 -
The Influence of Cognitive Decline on Quality of Life After Coronary Bypass
|
||
Enrolling by invitation |
NCT03999398 -
Short and Long-term Results of PCI in no Touch Vein-graft.
|
||
Recruiting |
NCT05414331 -
WithDRawal Impact Of Postoperative Beta-Blocker
|
N/A | |
Completed |
NCT02981680 -
Effect of Remote Ischemic Preconditioning on the Incidence of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery
|
N/A | |
Completed |
NCT00600704 -
Impact of Fluid Restriction Policy in Reducing the Use of Red Cells in Cardiac Surgery
|
N/A | |
Completed |
NCT06013605 -
Effect of Walking Exercise on Functional Capacity and Productivity in Patients After Coronary Artery Bypass Graft
|
N/A | |
Active, not recruiting |
NCT02731794 -
On-pump Beating Coronary Artery Bypass Grafting by Ventricular Assist
|
Phase 4 | |
Completed |
NCT02722213 -
Mindfulness & Stress Management Study for Cardiac Patients
|
N/A | |
Completed |
NCT01285271 -
A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon
|
Phase 3 | |
Completed |
NCT00911976 -
Study of the Xience V Everolimus-eluting Stent in Saphenous Vein Graft Lesions
|
Phase 4 | |
Completed |
NCT00823082 -
Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
|
Phase 2 |